Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nevanimibe is an orally active and selective inhibitor of acyl-coenzyme A:cholesterol O-acyltransferase 1 (ACAT1) (EC50 of 9 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Nevanimibe is an orally active and selective inhibitor of acyl-coenzyme A:cholesterol O-acyltransferase 1 (ACAT1) (EC50 of 9 nM). |
Targets&IC50 | ACAT2:368 nM (EC50), ACAT1:9 nM (EC50) |
In vitro | In H295R human adrenocortical carcinoma cells, Nevanimibe(ATR-101) decreases the formation of cholesteryl esters and increases FC levels, demonstrating potent inhibition of ACAT1 activity.?Caspase-3/7 levels and terminal deoxynucleotidyl transferase 2'-deoxyuridine 5'-triphosphate nick end labeled-positive cells are increased by ATR-101 treatment, indicating activation of apoptosis[1]. |
Synonyms | ATR-101, PD-132301 |
Molecular Weight | 421.62 |
Formula | C27H39N3O |
CAS No. | 133825-80-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Nevanimibe 133825-80-6 Others PD 132301 ATR-101 PD-132301 ATR 101 PD132301 ATR101 inhibitor inhibit